Increased resistance in BALB/c mice to reinfection with Candida albicans is due to immunoneutralization of a virulence-associated immunomodulatory protein

References

1. Arala-Chaves M. P, Ribeiro Ados S, Vilanova M, Porto M. T, Santarem M. G., Lima M. 1988; Correlation between B-cell mitogenicity and immunosuppressor effects of a protein released by porcine monocytes infected with African swine fever virus. Am J Vet Res 49:1955–1961
   [Google Scholar]
2. Balaban N, Goldkorn T, Nhan R. T. 8 other authors 1998; Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus . Science 280:438–440
   [Google Scholar]
3. Banerjee U, Mohapatra L. N., Kumar R. 1985; Effect of immunization with formalin killed cells in complete Freund's adjuvant in experimental candidosis. Indian J Med Res 81:454–458
   [Google Scholar]
4. Blander S. J., Horwitz M. A. 1989; Vaccination with the major secretory protein of Legionella pneumophila induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease. J Exp Med 169:691–705
   [Google Scholar]
5. Bruno T. F, Buser D. E, Syme R. M, Woods D. E., Mody C. H. 1998; Pseudomonas aeruginosa exoenzyme S is a mitogen but not a superantigen for human T lymphocytes. Infect Immun 66:3072–3079
   [Google Scholar]
6. Casadevall A. 1995; Antibody immunity and invasive fungal infections. Infect Immun 63:4211–4218
   [Google Scholar]
7. Casadevall A, Cassone A, Bistoni F, Cutler J. E, Magliani W, Murphy J. W, Polonelli L., Romani L. 1998; Antibody and/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute?. Med Mycol 36:Suppl. 195–105
   [Google Scholar]
8. Cassone A, Boccanera M, Adriani D, Santoni G., De Bernardis F. 1995; Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection. Infect Immun 63:2619–2624
   [Google Scholar]
9. Dugas B, Paul-Eugene N, Genot E, Mencia-Huerta J. M, Braquet P., Kolb J. P. 1991; Effect of bacterial toxins on human B cell activation. II. Mitogenic activity of the B subunit of cholera toxin. Eur J Immunol 21:495–500
   [Google Scholar]
10. Eckstein M, Barenholz Y, Bar L. K., Segal E. 1997; Liposomes containing Candida albicans ribosomes as a prophylactic vaccine against disseminated candidiasis in mice. Vaccine 15:220–224
    [Google Scholar]
11. Elin R. J, Edelin J. B., Wolff S. M. 1974; Infection and immunoglobulin concentrations in Chediak–Higashi mice. Infect Immun 10:88–91
    [Google Scholar]
12. Feng S.-H., Lo S.-C. 1994; Induced mouse spleen B-cell proliferation and secretion of immunoglobulin by lipid-associated membrane proteins of Mycoplasma fermentans incognitus and Mycoplasma penetrans . Infect Immun 62:3916–3921
    [Google Scholar]
13. Ferreira P, Soares R, Ribeiro A., Arala-Chaves M. 1988; Correlation between specific immunosuppression and polyclonal B cell activation induced by a protein secreted by Streptococcus mutans . Scand J Immunol 27:549–554
    [Google Scholar]
14. Ferreira P, Brás A, Tavares D, Vilanova M, Ribeiro A, Videira A., Arala-Chaves M. 1997; Purification, and biochemical and biologic characterization of an immunosuppressive and lymphocyte mitogenic protein secreted by Streptococcus sobrinus . Int Immunol 9:1735–1743
    [Google Scholar]
15. Giger D. K, Domer J. E., McQuitty J. T. Jr 1978; Experimental murine candidiasis: pathological and immune responses to cutaneous inoculation with Candida albicans . Infect Immun 19:496–509
    [Google Scholar]
16. Han Y., Cutler J. E. 1995; Antibody response that protects against disseminated candidiasis. Infect Immun 63:2714–2719
    [Google Scholar]
17. Han Y., Cutler J. E. 1997; Assessment of a mouse model of neutropenia and the effect of an anti-candidiasis monoclonal antibody in these animals. J Infect Dis 175:1169–1175
    [Google Scholar]
18. Han Y, Morrison R. P., Cutler J. E. 1998; A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection. Infect Immun 66:5771–5776
    [Google Scholar]
19. Han Y, Riesselman M. H., Cutler J. E. 2000; Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody. Infect Immun 68:1649–1654
    [Google Scholar]
20. Hector R. F, Domer J. E., Carrow E. W. 1982; Immune responses to Candida albicans in genetically distinct mice. Infect Immun 38:1020–1028
    [Google Scholar]
21. Horwitz M. A, Lee B.-W, Dillon B. J., Harth G. 1995; Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis . Proc Natl Acad Sci U S A 92:1530–1534
    [Google Scholar]
22. Itoh T, Satoh H, Isono N, Rikiishi H., Kumagai K. 1992; Mechanism of stimulation of T cells by Streptococcus pyogenes : isolation of a major mitogenic factor, cytoplasmic membrane-associated protein. Infect Immun 60:3128–3135
    [Google Scholar]
23. Kierszenbaum F, Cuna W. R, Beltz L. A., Sztein M. B. 1990; Trypanosomal immunosuppressive factor: a secretion product(s) of Trypanosoma cruzi that inhibits proliferation and IL-2 receptor expression by activated human peripheral blood mononuclear cells. J Immunol 144:4000–4004
    [Google Scholar]
24. Klapproth J.-M, Donnenberg M. S, Abraham J, Mobley H. L., James S. P. 1995; Products of enteropathogenic Escherichia coli inhibit lymphocyte activation and lymphokine production. Infect Immun 63:2248–2254
    [Google Scholar]
25. Levy R, Segal E., Barr-Nea L. 1985; Systemic candidiasis in mice immunized with Candida albicans ribosomes. Mycopathologia 91:17–22
    [Google Scholar]
26. Lima M, Bandeira A, Portnoi D, Ribeiro A., Arala-Chaves M. P. 1992; Protective effect of a T-cell-dependent, immunosuppressive, B-cell-mitogenic protein (F3′ EP-Si or p90) produced by Streptococcus intermedius . Infect Immun 60:3571–3578
    [Google Scholar]
27. Louria B. D. 1985; Candida infections in experimental animals. In Candidiasis Edited by Bodey Gerald P., Fainstein Victor. New York: Raven Press;
    [Google Scholar]
28. Lowry O. H, Rosebrough N. J, Farr A. L., Randall R. J. 1951; Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
    [Google Scholar]
29. Mahanty S, Greenfield R. A, Joyce W. A., Kincad P. W. 1988; Inoculation candidiasis in a murine model of severe combined immunodeficiency syndrome. Infect Immun 56:3162–3166
    [Google Scholar]
30. Mathews R., Burnie J. 1996; Antibodies against Candida : potential therapeutics?. Trends Microbiol 4:354–358
    [Google Scholar]
31. Mencacci A, Torosantucci A, Spaccapelo R, Romani L, Bistoni F., Cassone A. 1994; A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production and anticandidal protection in mice. Infect Immun 62:5353–5360
    [Google Scholar]
32. Miyoshi-Akiyama T, Imanishi K., Uchiyama T. 1993; Purification and partial characterization of a product from Yersinia pseudotuberculosis with the ability to activate human T cells. Infect Immun 61:3922–3927
    [Google Scholar]
33. Mody C. H, Buser D. E, Syme R. M., Woods D. E. 1995; Pseudomonas aeruginosa exoenzyme S induces proliferation of human T lymphocytes. Infect Immun 63:1800–1805
    [Google Scholar]
34. Mourad S., Friedman L. 1961; Active immunization of mice against Candida albicans . Proc Soc Exp Biol Med 106:570–572
    [Google Scholar]
35. Pal P. J., Horwitz M. A. 1992; Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect Immun 60:4781–4792
    [Google Scholar]
36. Reitnauer P. J, Brown L. R, Hank J. A., Soudel P. M. 1986; Presentation of Candida albicans and purified protein derivative soluble antigens by Epstein–Barr virus transformed human lymphoblastoid B-cell lines. Cell Immunol 99:196–208
    [Google Scholar]
37. Ribeiro A, Arala-Chaves M. P, Vilanova M, Porto M. T., Coutinho A. 1991; Role of B and T lymphocytes in the specific immunosuppressive induced by a protein released by porcine monocyte infected with African swine fever virus. Int Immunol 3:165–174
    [Google Scholar]
38. Santarem M. M.-G, Porto M. T, Ferreira P, Soares R., Arala-Chaves M. 1987; Semipurification of an immunosuppresssor substance secreted by Streptococcus mutans that plays a role in the protection of the bacteria in the host. Scand J Immunol 26:755–761
    [Google Scholar]
39. Soares R, Ferreira P, Santarem M. M. G, Teixeira da Silva M., Arala-Chaves M. 1990; Low T- and B-cell reactivity is an apparently paradoxical request for murine immunoprotection against Streptococcus mutans . Scand J Immunol 31:361–365
    [Google Scholar]
40. Stevens M. G, Olesen S. C, Pugh G. W., Brees D. 1995; Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51. Infect Immun 63:264–270
    [Google Scholar]
41. Sun X, Burns J. B, Howell J. M., Fujinami R. S. 1998; Suppression of antigen-specific T cell proliferation by measles virus infection: role of a soluble factor in suppression. Virology 246:24–33
    [Google Scholar]
42. Tavares D, Salvador A, Ferreira P., Arala-Chaves M. 1993; Immunological activities of a Candida albicans protein which plays an important role in the survival of the microorganism in the host. Infect Immun 61:1881–1888
    [Google Scholar]
43. Tavares D, Ferreira P, Vilanova M, Videira A., Arala-Chaves M. 1995; Immunoprotection against systemic candidiasis in mice. Int Immunol 7:785–796
    [Google Scholar]
44. Tavares D, Ferreira P., Arala-Chaves M. 2000; Increased resistance to systemic candidiasis in athymic or interleukin-10-depleted mice. J Infect Dis 182:266–273
    [Google Scholar]
45. Timoney J. F, Gillespie J. H, Scott F. W., Barlough J. E. 1988; Part II. The pathogenic fungi. In Microbiology and Infectious Diseases of Domestic Animals, 8th edn. pp 383–394 Edited by Hagan W. A., Bruner D. W. Comstock Publishing Associates;
    [Google Scholar]
46. Urquhart G. M, Armour J, Duncan J. L, Dunn A. M., Jennings F. W. 1998; Protozoologia veterinária. In Parasitologia Veterinária pp 210–214 SA: Guanabara Koogan;
    [Google Scholar]
47. Ying M., Weis J. J. 1993; Borrelia burgdorferi outer surface lipoproteins OspA and OspB posses B-cell mitogenic and cytokine-stimulatory properties. Infect Immun 61:3843–3853
    [Google Scholar]